HALEY LANDRY: Open Payments
NPI 1265930077 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,725 in 124 payments from 20 companies in 2025. Trend: 2023 $1,843 · 2024 $2,080 · 2025 $2,725
Food & beverage: $2,708Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 35 | $625 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $317 |
| Regeneron Healthcare Solutions, Inc. | 7 | $268 |
| AstraZeneca Pharmaceuticals LP | 13 | $258 |
| Verona Pharma, Inc. | 9 | $192 |
| Grifols USA, LLC | 10 | $180 |
| GENZYME CORPORATION | 7 | $151 |
| Viatris Specialty LLC | 6 | $130 |
| Insmed, Inc. | 7 | $126 |
| Amgen Inc. | 4 | $72 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA, Ohtuvayre, TEZSPIRE, Prolastin-C Liquid, OFEV, FASENRA.
Industry payments across LA — which companies pay providers there.
